When Jean Shipos had an ovarian cancer recurrence back in 2003, her daughter knew that she wanted to do something based on what she saw her mother go through. Fast-forward three years, Jean and her daughter decided to host a small tea party to help raise awareness of the disease. This “small” tea ended up … Continued
(December 17, 2015) This morning in London, researchers announced the long-awaited final results of the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). The trial showed that average-risk, post-menopausal women who were screened for ovarian cancer based on a test called ROCA (Risk of Ovarian Cancer Algorithm) were not less likely to die from … Continued
Sisters Jamie and Dawn Twedt launch a multifaceted campaign to make a difference.
(12/14/15) | In 2015, OCRF grantees made several significant advances in the fight against ovarian cancer, including: These discoveries are the direct result of generous donations from people like you. Progress is made every day, and the future is full of promise – with even more important successes to come. Thank you for supporting cutting-edge … Continued
Last week the United States Preventive Services Task Force (USPSTF) released its fifth report to Congress highlighting women’s health as a high priority gap in clinical preventative services. Recognizing the reproductive and biologic differences in women, as well as such external factors as home and work environments and economic and educational resources, the USPSTF has … Continued
(December 4, 2015) According to the results of a phase III trial of over 1,000 women, women with advanced ovarian cancer gained significant delays in the progression of their disease when they were treated with the drug nintedanib plus carboplatin/paclitaxel, compared with women treated with carboplatin/paclitaxel alone. The results of the study were published in … Continued
2015 marks the 10th anniversary of the Colorado Ovarian Cancer Alliance (COCA), an organization dedicated to promoting awareness and early detection of ovarian cancer through advocacy and education efforts, while also providing support to women affected by ovarian cancer. COCA got its start in 2005, when a local ovarian cancer support group decided to form … Continued
In September, a group of ladies from Collierville, TN hosted their first Teal Tea Luncheon to support the Ovarian Cancer National Alliance. The community event included tea, lunch and speaker Susan Leighton who spoke about the signs and symptoms of ovarian cancer. At the luncheon, they hosted a silent auction with donations from the community. … Continued
(December 2, 2015) Research funded in part by an OCRF grant to Rachel Grisham, MD has identified new, potentially targetable mutations in patients with low grade serous ovarian cancer. Dr. Grisham is a medical oncologist at Memorial Sloan Kettering Cancer Center in New York and is a 2014 recipient of the Liz Tilberis Early Career … Continued
(December 1, 2015) Research funded in part by Ovarian Cancer Research Fund, and published in PNAS, offers new insights into how ovarian cancer grows—and the potential to stop it. Can any cancer cell form another tumor, or is it only select cancer stem cells that give rise to new cancer cells? The answer, a new … Continued
(November 20, 2015) A study published in BMC Cancer demonstrates that ovarian cancer patients who had a history of oral contraceptive use had better outcomes than those who had not previously used them. Dr. Aminah Jatoi and co-author Dr. Ellen Goode, both of the Mayo Clinic, examined 1,398 cases during a thirteen year period and … Continued
(Nov. 19, 2016) In research published this month in Gynecologic Oncology, a group of Canadian researchers have found that long-term survival is not associated with BRCA mutation status in ovarian cancer patients. Past research has shown that after a diagnosis of ovarian cancer, positive BRCA mutation status confers a mortality benefit that diminishes with time. In … Continued
Get email updates about research news, action alerts, and ways to join the fight.
